Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunochemotherapy”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Not applicableUnknownNCT06103890
What this trial is testing

Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 100
Not applicableNot Yet RecruitingNCT06722495
What this trial is testing

Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

Who this might be right for
SBRTNeoadjuvant ImmunochemotherapyLA HNSCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Testing effectiveness (Phase 2)Looking for participantsNCT06403878
What this trial is testing

Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sichuan University 68
Testing effectiveness (Phase 2)Looking for participantsNCT06288360
What this trial is testing

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Who this might be right for
Cervical CancerLocally Advanced Cervical CancerPD-L1 Negative+1 more
Tongji Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05675579
What this trial is testing

A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07145931
What this trial is testing

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaSkull Base--CancerNeoadjuvant Chemoimmunotherapy+1 more
Sun Yat-sen University 24
Not applicableLooking for participantsNCT07088354
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more
Tongji Hospital 300
Not applicableNot Yet RecruitingNCT06285058
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Who this might be right for
Deep Learning ModelPathological Complete ResponseNon-small Cell Lung Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090707
What this trial is testing

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

Who this might be right for
HNSCCPD-1Radiotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04506554
What this trial is testing

Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fox Chase Cancer Center 81
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05319574
What this trial is testing

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT06354140
What this trial is testing

PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY

Who this might be right for
Esophageal Squamous Cell Carcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 45
Testing effectiveness (Phase 2)Looking for participantsNCT05870800
What this trial is testing

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Who this might be right for
Stage I Colon CancerStage II Colon CancerStage III Colon Cancer
Baylor College of Medicine 28
Not applicableLooking for participantsNCT07133958
What this trial is testing

A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)
Zhujiang Hospital 35
Not applicableStudy completedNCT05615129
What this trial is testing

Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting

Who this might be right for
Esophagus Cancer
Guangdong Provincial People's Hospital 350
Not applicableStudy completedNCT05637580
What this trial is testing

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Who this might be right for
Non Small Cell Lung CancerImmunotherapyChemotherapy+1 more
Guangdong Provincial People's Hospital 110
Not applicableUnknownNCT06235164
What this trial is testing

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

Who this might be right for
Locally Advanced Gastric Cancer
Fujian Medical University 585
Testing effectiveness (Phase 2)Looking for participantsNCT07003620
What this trial is testing

Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial

Who this might be right for
Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 34
Load More Results